Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 2;12:1756286419887596. doi: 10.1177/1756286419887596

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Analysis of lymphocyte subgroups during cladribine therapy.

Measurement of lymphocyte subgroups of selected patients (Clad3, Clad6, Clad9, Clad10, Clad11, Clad12). In (a) absolute numbers are presented while (b) shows the percentage of CD3+, CD19+, CD4+, and CD8+ cells. Baseline and follow-up periods are as defined in Figure 1.